The company intends to use the funds to launch U-SURGAR, a software solution dedicated to female patients suffering from fibroids and adenomyosis and to finalize and commercialize L-SURGAR and K-SURGAR, aimed at treating liver and kidney cancers respectively.

Company Information

Company Status

Private & Independent

Industry

Medical Devices & Instruments

Mailing Address

22 allée Alan Turing
Clermont-Ferrand, 63000
France

Phone

Undisclosed

Website

www.surgar-surgery.com

Email Address

[email protected]

Overview

SURGAR project was born under the impulse of four co-founders: Nicolas Bourdel, Adrien Bartoli, Michel Canis and Bertrand Le Roy. Our company builds upon the work of the EnCoV (Endoscopy and Computer Vision) research team. This team, specialised in computer vision, is part of the Image Guided Therapy (IGT) department of the UMR6602 Institut Pascal associating the CNRS, the University of Clermont Auvergne (UCA) and Clermont Auvergne INP. It is also affiliated to the University Hospital (CHU) of Clermont-Ferrand.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Nicolas Bourdel

Chief Marketing Officer

Benoît Ducourtieux

Chief Operating Officer

Cécile Issert

Chief Scientific Officer

Adrien Bartoli

Chief Scientific Officer

Julien Peyras

Chief Technical Officer

Prasad Samarakoon

VP - Regulatory Affairs

Héloïse Macaire

Browse more venture capital transactions:

Prev: 9/26/2024: ÄIO venture capital transaction
Next: 9/26/2024: Mendaera venture capital transaction

Share this article

About Database of VC Transactions

We do our best to report on tech company VC transactions. VC investment data records on this site come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary